Mostrar el registro sencillo

dc.contributor.authorHierro Recio, Luis Ángel
dc.contributor.authorPatiño Rodríguez, David
dc.contributor.authorAtienza Montero, Pedro
dc.contributor.authorGarzón Gordón, Antonio José
dc.contributor.authorCantarero Prieto, David 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-03-07T12:32:12Z
dc.date.available2023-03-07T12:32:12Z
dc.date.issued2023-01
dc.identifier.issn2191-1991
dc.identifier.urihttps://hdl.handle.net/10902/28035
dc.description.abstractBackground: After the emergence of the first vaccines against the COVID-19, public health authorities have promoted mass vaccination in order to achieve herd immunity and reduce the effects of the disease. Vaccination rates have differed between countries, depending on supply (availability of resources) and demand (altruism and resistance to vaccination) factors. Methods: This work considers the hypothesis that individuals' health altruism has been an important factor to explain the different levels of vaccination between countries, using the number of transplants as a proxy for altruism. Taking European Union's countries to remove, as far as possible, supply factors that might affect vaccination, we carry out cross-sectional regressions for the most favorable date of the vaccination process (maximum vaccination speed) and for each month during the vaccination campaign. Results: Our findings confirm that altruism has affected vaccination rates against the COVID-19. We find a direct relationship between transplants rates (proxy variable) and vaccination rates during periods in which the decision to be vaccinated depended on the individual's choice, without supply restrictions. The results show that other demand factors have worked against vaccination: political polarization and belonging to the group of countries of the former Eastern bloc. Conclusions: Altruism is a useful tool to define future vaccination strategies, since it favors the individuals' awareness for vaccination.es_ES
dc.description.sponsorshipFunding for the study was provided by the Instituto de Investigación Marqués de Valdecilla (INNVAL20/03 project) (Spain).es_ES
dc.format.extent12 p.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (part of Springer Nature)es_ES
dc.rightsAttribution 4.0 Internationales_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceHealth Economics Review, 2023, 13(1), 2es_ES
dc.subject.otherAltruismes_ES
dc.subject.otherVaccineses_ES
dc.subject.otherCOVID-19es_ES
dc.subject.otherHesitancyes_ES
dc.subject.otherExternalityes_ES
dc.subject.otherHerd immunityes_ES
dc.subject.otherPublic healthes_ES
dc.titleThe effect of altruism on COVID-19 vaccination rateses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1186/s13561-022-00415-6es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1186/s13561-022-00415-6
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International